Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer
OncoDoc2
Impact of the OncoDoc2 Decision Support System on Compliance of Multidisciplinary Staff Meeting Decisions With Clinical Practice Guidelines in the Management of Non-metastatic Breast Cancer.
1 other identifier
interventional
816
1 country
1
Brief Summary
The objective of the study is to evaluate how the use of OncoDoc2, a computerized guideline-based decision support system, could improve the compliance of multidisciplinary staff meeting decisions with local clinical practice guidelines in the management of non-metastatic breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Dec 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2008
CompletedFirst Posted
Study publicly available on registry
August 5, 2008
CompletedStudy Start
First participant enrolled
December 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedSeptember 4, 2013
September 1, 2013
1.3 years
July 31, 2008
September 2, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compliance of multidisciplinary staff meeting (MSM) decisions with OncoDoc2 guideline-based recommendations at one year : MSM decisions are recorded on a weekly basis.
Every week
Secondary Outcomes (3)
Compliance of actually administered treatments with OncoDoc2 recommendations at 18 months (treatments administration may last until 8 months after the therapeutic decision has been taken by MSMs)
at 18 months
typology of non-compliant reasons for both MSM decisions and treatments administration
at 18 months
patient profiles associated with non-guideline-compliant therapeutic decisions.
at 18 months
Study Arms (2)
1
EXPERIMENTALmedical decision based on computerized guideline-based decision support system
2
NO INTERVENTIONInterventions
Introduction of a computer-based decision support system in the medical decision process
Eligibility Criteria
You may qualify if:
- Non metastatic, including invasive and in situ, breast cancers as well as axillary cancer without breast tumor.
- At least one therapeutic MSM decision.
You may not qualify if:
- Breast disease without cancer
- Metastatic breast cancer
- Male breast cancer
- Breast cancer cases when medical records are not accessible to investigators
- Management but not therapeutic breast cancer decisions (diagnostic investigations, treatment follow-up, delayed decisions…)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de gynecologie obstetrique, Hopital Tenon
Paris, 75020, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serge UZAN, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2008
First Posted
August 5, 2008
Study Start
December 1, 2008
Primary Completion
April 1, 2010
Study Completion
April 1, 2011
Last Updated
September 4, 2013
Record last verified: 2013-09